Using Genetics to Plan Future Randomized Trials of Lipoprotein(a) Lowering-How Much Reduction, for How Long, and in Whom?
- PMID: 31017615
- DOI: 10.1001/jamacardio.2019.1107
Using Genetics to Plan Future Randomized Trials of Lipoprotein(a) Lowering-How Much Reduction, for How Long, and in Whom?
Comment on
-
Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis.JAMA Cardiol. 2019 Jun 1;4(6):575-579. doi: 10.1001/jamacardio.2019.1041. JAMA Cardiol. 2019. PMID: 31017618 Free PMC article.